- Home
- » Tags
- » Darbepoetin alfa
Top View
- Specialty Drug List
- DARBEPOETIN ALFA, EPOETIN ALFA, and METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA Policy Number: PHARMACY 080.29 T2 Effective Date: October 1, 2017
- Injections: Drugs AD Policy
- Clinical Pharmacology Biopharmaceutics Review(S)
- Aranesp Medication Guide
- Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 2582 Date: November 2, 2012 Change Request 8050
- Aranesp (Darbepoetin Alfa) Is an Erythropoiesis-Stimulating Protein That Is Produced in Chinese Hamster Ovary (CHO) Cells by Recombinant DNA Technology
- The Use of Erythropoiesis-Stimulating Agents With
- Omontys, INN-Peginesatide
- Aranesp® (Darbepoetin Alfa) Injection
- Aranesp® (Darbepoetin Alfa)
- Article Peginesatide for Maintenance Treatment of Anemia In
- A Phase 3 Randomized Placebo-Controlled Trial of Darbepoetin Alfa in Patients with Anemia and Lower-Risk Myelodysplastic Syndromes
- Mircera (Methoxy Polyethylene Glycol-Epoetin
- Darbepoetin Alfa, Aranesp, Amgen Package Insert
- Difference for ME.”
- Aranesp® (Darbepoetin Alfa) Injection
- Aranesp®(Darbepoetin Alfa)
- The Impact of Biosimilar Competition in Europe Contents
- Darbepoetin Alfa) Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Effective 06/01/2021
- Erythropoiesis-Stimulating Agents – Oxford Clinical Policy
- WHO EML 2016-2017 - Erythropoietin-Stimulating Agents December 2016
- Risk-Management-Plan Summary
- Thrombopoietic Factors in Chronic Bone Marrow Failure States: the Platelet Problem Revisited
- Erythropoiesis Stimulating Proteins Epoetin Alfa (EPO), Darbepoetin Alfa (DPA)
- Colony Stimulating Factors Srx-0047
- 262 BCBSA Reference Number: 5.01.04
- Initial Criteria
- THE IMPACT of BIOSIMILAR COMPETITION in EUROPE October 2019
- Colony Stimulating Factors: Filgrastim (Neupogen®); Filgrastim-Aafi
- Product Monograph
- SIOP Education Book.P65
- Specialty Pharmacy Medication List
- Lessons Learned from Peginesatide in the Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis
- Purification and Characterization of Recombinant Darbepoetin Alfa From
- Unraveling the Mystery of Erythropoietin-Stimulating Agents in Cancer Promotion Kelly A
- Epoetin Alfa, Beta, Theta and Zeta; And, Darbepoetin Alfa) for Treating Cancer- Treatment Induced Anaemia (Including Review of TA142
- ARANESP® (Darbepoetin Alfa)
- Quarterly Pharmacy Changes Effective July 1, 2021 – Part 2
- Aranesp® (Darbepoetin Alfa)